iBio Inc. Shares Near 52-Week Low - Market Mover
The shares closed 0.8% above its 52-week low of $0.51, with trading volume lower than its 30 day average
Jan 11, 2022 by Kwhen Finance Editors
iBio Inc. (IBIO) shares closed today at 0.8% above its 52 week low of $0.51, giving the company a market cap of $114M. The stock is currently down 4.4% year-to-date, down 56.3% over the past 12 months, and down 86.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 40.4% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| iBio Inc. | -1.6 | -4.4 | -56.3 | -81.5 | 2.3 |
| Dow Jones Industrial Average | -0.4 | -0.3 | 18.5 | -2.3 | 22.9 |
| S&P 500 Index | -0.1 | -1.9 | 23.9 | -3.6 | 27.3 |
| Health Care | -0.0 | -5.2 | 13.2 | -6.3 | 20.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 408.7%
- The company's stock price performance over the past 12 months lags the peer average by 73.1%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| iBio Inc. | IBIO | 0 | -4.4 | -56.3 | -81.5 | 2.3 |
| Peer Avg | N/A | 8.1 | -0.9 | -32.5 | -16.1 | 19.5 |
| Johnson & Johnson | JNJ | 25.6 | 1.7 | 11.4 | -2.3 | 16.8 |
| Emergent Biosolutions Inc | EBS | 11.6 | 12.2 | -49.8 | -62.1 | 61.3 |
| Nektar Therapeutics | NKTR | -4.7 | -6.1 | -34.0 | ||
| Genocea Biosciences Inc | GNCA | 0 | -11.2 | -57.6 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: